PMHNP Certification Q & A

PMHNP Certification Q & A

By Fitzgerald Health Education AssociatesEducationHow ToCourses
Download on the App Store

PMHNP Certification Q & A episodes

  • Evaluating Child Attachment

    The PMHNP is evaluating a family at the request of county social services. A mother, father, 8-year-old and 2-year-old are present for the evaluation. The NP notes that the 2-year-old clings excessively to the parents, despite the fact that the parents do not seem to be particularly responsive to the child’s caution.  The 2-year-old does not exhibit typical curiosity about his new environment and does not express any curiosity about the PMHNP. 

    These behaviors are consistent with:

    A. Separation anxiety disorder 

    B. Normal behavior

    C. Autism spectrum disorder. 

    D. Insecure-ambivalent attachment

    ---

    YouTube: https://www.youtube.com/watch?v=Q53ltO03TKU&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=96



    8 min
  • Assessing Cognitive Changes

    A 78-year-old man presents for a follow-up visit. Two months ago he was started on sertraline  for major depressive disorder and has been titrated up to 100 mg daily. Today his daughter reports that she cannot really evaluate if his mood has improved because he seems to have become confused. The patient’s daughter reports a distinct new onset confusion and forgetfulness. 

    The PMHNP considers the most likely cause of his confusion to be: 

    A. Urinary tract infection. 

    B. Hyponatremia

    C. Alzheimer’s disease 

    D. Depression 

    ---

    YouTube: https://www.youtube.com/watch?v=HGxzaaVSVxk&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=95



    7 min
  • Piaget Sensorimotor Principles

    Cognitive assessment in children characterizes stages of development consistent with Piaget’s developmental theory. One of the cognitive principles typically developed during the sensorimotor stage is: 

    A. Object permanence

    B. Animalistic thinking

    C. Phenomenalistic causality 

    D. Learning without reasoning. 

    YouTube: https://www.youtube.com/watch?v=AIZ5H14yUqI&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=94

    7 min
  • Fluoxetine Adverse Effects

    A 12-year-old patient is being seen today in follow-up after being started on fluoxetine 1 month ago for a diagnosis of generalized anxiety disorder.  The patient and her father both report that while there does appear to be a mild improvement in anxiety, some adverse effects have developed about which they are concerned. 

    Which of the following is not an expected adverse effect and is a cause for concern?  

    A. Vivid nightmares 

    B. Diaphoresis 

    C. Restless legs 

    D. Impulsivity

    ---

    YouTube: https://www.youtube.com/watch?v=6onROBl73UE&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=93



    7 min
  • PTSD Clinical Evaluation

    The PMHNP is evaluating a patient who presents complaining of panic attacks that occur for no identifiable reason. The patients has been treated for these previously with a variety of pharmacotherapies that did not provide any meaningful improvement. Upon further conversation, the NP learns that the patient experienced a near-fatal bicycle accident  4 years ago after being hit by a car. 

    When considering a diagnosis of PTSD, the NP explores his history for all of the following diagnostic criteria except: 

    A. Intrusion symptoms. 

    B. Angry outbursts. 

    C. Negative cognition 

    D. Avoidance symptoms. 

    ---

    YouTube: https://www.youtube.com/watch?v=QQ-KgQYOuSg&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=92



    7 min
  • OCD SSRI Dose Escalation

    J.B. is a 41-year-old female patient who is being managed for obsessive compulsive disorder. She has been in exposure response therapy (ERT) for several months with marginal improvement, but she has never approached true remission. At one time she was on fluvoxamine with notable improvement, but after a few months it ceased to produce any notable impact and after conferring with her therapist she was converted to fluoxetine 20 mg qd. After two months she was still struggling with symptoms, so two months ago her dose was increased to 40 mg qd. Today she presents for follow-up, reporting no notable improvement with pharmacotherapy. She continues to engage in psychotherapy but at this point is becoming very frustrated.  

    The appropriate approach at this point would be to: 

    A. Continue fluoxetine 40 mg daily for one more month and reassess 

    B. Convert the patient to therapy with a tricyclic antidepressant 

    C. Continue fluoxetine at 40 mg daily and consider a change in therapy. 

    D. Increase the fluoxetine to 60 mg daily and reassess in four to eight weeks 

    ---

    YouTube: https://www.youtube.com/watch?v=GHa21K_Zprc&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=91



    10 min
  • Hypnopompic Hallucination Counseling

    The PMHNP is evaluating a patient with significant anxiety and depressive symptoms. In the course of the evaluation the NP further appreciates that the patient is having hypnopompic hallucinations, and that the patient is very concerned about this because his uncle has schizophrenia. 

    The PMHNP advises the patient that: 

    A. There are a variety of pharmacologic options that can be helpful. 

    B. The hallucinations are benign and not a cause for concern.

    C. There is no need for intervention unless they are accompanied by sleep paralysis.

    D. The sensory systems involved will dictate the need for further evaluation and treatment.

    ---

    YouTube: https://www.youtube.com/watch?v=K-RKNH9QqU0&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=90

    8 min
  • Stimulant Therapy Growth Counseling

    A.J. is an 8-year-old male who is under the care of the PMHNP for ADHD.  His symptoms are profound, and the recommendation is to begin psychostimulant therapy along with behavioral therapy.  The parents are concerned because they have read that psychostimulant therapy can impact growth and final adult height if the child starts taking it before the growth spurt of adolescence.

    The most appropriate response to the parents is to say that: 

    A. The impact on growth can be minimized by taking breaks from the medication on weekends and over the summer

    B. This concern is not supported by the evidence and that there is no impact on growth when appropriately prescribed 

    C. The impact on growth can be significant and the best management for this patient is likely a non-stimulant option 

    D. The cardiovascular consequences are  actually the bigger concern. 

    ---

    YouTube: 



    9 min
  • Adolescent Behavioral Assessment

    A 14-year-old patient has been managed for the last year with fluoxetine 40 mg daily for a diagnosis of generalized anxiety disorder. She had been doing well, but today her mother reports that ever since returning to school after the summer break she has been distant, sullen, argumentative and defiant. She has been spending time with new friends from school and is always out somewhere with them.

    The PMHNP recognizes that today’s appointment should include use of which of the following objective tools?  

    A. The AIMS tool 

    B. The BPRS 

    C. The MDQ 

    D. The CRAFFT tool

    ---

    YouTube: https://www.youtube.com/watch?v=jQmzYmvXL-o&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=88



    10 min
  • Treatment of Parkinson’s Psychosis

    PMHNP is asked to evaluate a 71-year-old male patient who is reportedly having visual hallucinations. His adult daughter accompanies him to the appointment and reports that he was diagnosed with Parkinson’s disease approximately 2 years ago. It began with the classic motor symptoms, but over the last year he has developed more and more difficulty with memory loss, difficulty with decision making, and episodes of depression and apathy. Sinemet has helped his motor symptoms, but he has not responded well to medications for cognitive symptoms.  A few months ago he started having visual hallucinations. At first it was a sense of things moving in his peripheral vision, but lately he is seeing people who are not there, or interpreting inanimate objects as people. 

    Which of the following is the most appropriate medication for this patient? 

    A. Bupropion (Wellbutrin)

    B. Pimavanserin (Nuplazid)

    C. Quetiapine (Seroquel) 

    D. Sertraline (Zoloft)



    10 min

About PMHNP Certification Q & A

From the publisher's feed

This podcast is for NP students studying to pass their PMHNP certification exam. Expert Fitzgerald faculty clinicians share their knowledge and experience to help you dissect the anatomy of a test…

Best of PMHNP Certification Q & A

Ranked by our users in the last 21 days

More shows like PMHNP Certification Q & A

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,335 Listeners

My Favorite Murder with Karen Kilgariff and Georgia Hardstark by Exactly Right and iHeartPodcasts

My Favorite Murder with Karen Kilgariff and Georgia Hardstark

171,835 Listeners

NEI Podcast by Neuroscience Education Institute

NEI Podcast

138 Listeners

Crime Junkie by Audiochuck

Crime Junkie

369,057 Listeners

Armchair Expert with Dax Shepard by Armchair Umbrella

Armchair Expert with Dax Shepard

69,559 Listeners

Psychopharmacology and Psychiatry Updates by Psychopharmacology Institute

Psychopharmacology and Psychiatry Updates

297 Listeners

The Carlat Psychiatry Podcast by The Carlat Psychiatry Podcast

The Carlat Psychiatry Podcast

569 Listeners

Dateline NBC by NBC News

Dateline NBC

46,605 Listeners

SmartLess by Jason Bateman, Sean Hayes, Will Arnett

SmartLess

57,804 Listeners

Betrayal Season 6 by iHeartPodcasts | Glass Podcasts

Betrayal Season 6

8,372 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

20,000 Listeners

Psychiatry Boot Camp by Mark Mullen, MD

Psychiatry Boot Camp

194 Listeners

PsychRounds: The Psychiatry Podcast by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller

PsychRounds: The Psychiatry Podcast

154 Listeners